News Releases

Select year
Categories

New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey

Dec 15, 2021 | Products

Read more

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

Nov 23, 2021 | Products

Read more

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment

Nov 22, 2021 | Pipeline | Products

Read more

Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey

Oct 11, 2021 | Products

Read more

Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey

Sep 08, 2021 | Products

Read more

Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries

Aug 02, 2021 | Pipeline | Products

Read more

New research reveals most Americans can’t identify the symptoms of depression

Jul 28, 2021 | Products

Read more

Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities

Jul 21, 2021 | Corporate | Products

Read more

Myriad Genetics Completes the Sale of Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences

Jun 01, 2021 | Corporate | Products

Read more

Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

May 19, 2021 | Pipeline | Products

Read more

Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment

Apr 28, 2021 | Products

Read more

Myriad Genetics Receives Additional Reimbursement for myChoice® Diagnostic System in Japan

Mar 24, 2021 | Products | Pipeline

Read more

Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services

Mar 02, 2021 | Pipeline | Products

Read more

New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer

Feb 12, 2021 | Pipeline | Products

Read more

GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels

Feb 08, 2021 | Products

Read more

Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis

Feb 02, 2021 | Products

Read more

Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan

Jan 19, 2021 | Products

Read more

Myriad Genetics Forms Strategic Partnership with Illumina in Oncology

Jan 11, 2021 | Products

Read more

Myriad Genetics Receives First Reimbursement Decision for myChoice® Diagnostic System in Japan, Enabling Women with Ovarian Cancer to Benefit from Treatment with Zejula®

Jan 08, 2021 | Products | Pipeline

Read more